Article Details

European Authorities Approve JHL Biotech's Clinical Trial Application for Dornase Alfa Biosimilar ...

Retrieved on: 2018-03-01 03:07:30

Tags for this article:

Click the tags to see associated articles and topics

European Authorities Approve JHL Biotech's Clinical Trial Application for Dornase Alfa Biosimilar .... View article details on hiswai:

Excerpt

<div>JHL is backed by premier financial firms, including <b>Kleiner Perkins Caufield &</b> <b>Byers</b>, Sequoia Capital, Biomark Capital, Milestone Capital, Fidelity, and the China Development Industrial Bank. JHL's mission is to provide the world with low-cost medicines of exceptional quality. JHL is focused on the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up